This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
miLab Platform ProductsImprove diagnostic workflows
Improve diagnostic workflows
and accessibility at once
Beyond DiagnosticsWe provide products and services that impact
We provide products and services that impact
one billion people's life in the world.
Noul focuses on the most challenging healthcare issues the world has yet to resolve.
We deliver innovative diagnostic solutions in blood and tissue diagnostics dramatically improve medical access and
conquer cancer.
Our Story in Numbers
- NVIDIA GTC selected AI Startups
- Top 0
- Cumulative investment (USD)
- 0million
- Annual sales growth (as of 2023)
- 0%
We continues to grow, moving toward the next stage.
- Patent registrations and applications
- 0cases, 0cases
- Cumulative orders for National R&D project (USD)
- 0million
- Researcher in company
- 0%
We creates innovation based on R&D and technology patents.
- Countries using miLab™
- 0countries
- Cumulative diagnosis using miLab™
- 0diagnoses
- Partner organizations
- 0+
miLab™ Solution leads the global blood and cancer diagnosis.
- Digitalize entire process (stain, scan, AI analyze)
- All inOne
- Time required for diagnosis (more than 2x improvement)
- Avg0mins
- Accuracy of test results (Based on miLab™ MAL)
- Sensitivity0% ,
Specificity0%
miLab™ Solution has dramatically improved the diagnostic process.
Noul Highlights
Find our latest news
View More-
NOUL at MEDICA 2024: Transforming Diagnostics with miLab™ Table of Contents Toggle Importance of Healthcare InnovationRole… Read MoreBlog | 2024.11.19
-
[Press Release] Noul Demonstrates ‘Expert-Level’ AI Diagnostic Performance in Europe… Results from Spain’s Carlos III Health Institute September 24, 2024 – Noul Co., Ltd. (CEO: David Lim, hereafter referred to as “Noul”) has proven the expert-level diagnostic performance of its AI in Europe. Noul presented the AI diagnostic performance results of miLab at the 2024 International Congress for Tropical Medicine and Malaria. The study, conducted by National… Read MoreNews | 2024.09.24
-
Noul Sustainability Report 2023-2024 In accordance with our Articles of Incorporation, Noul Co., Ltd. publishes sustainability reports to periodically review and disclose our corporate activities and achievements from economic, social, and environmental perspectives to our stakeholders. Through the annual publication of these sustainability reports, we aim to identify our ESG performance and areas… Read MoreNews | 2024.06.28
-
[Press Release] Noul Participates in a Malaria Project Initiated by U.S. CDC with Kenya Medical Research Institute June 17, 2024 – On-Device AI healthcare company, Noul, announced that it will jointly participate in a malaria diagnosis project initiated by U.S. Centers for Disease Control and Prevention (CDC) with the Kenya Medical Research Institute (KEMRI). The project will involve 2,000 patients who are tested for malaria at… Read MoreNews | 2024.06.17
-
[Press Release] On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference (Yongin, Korea) April 25, 2024 – Noul Co., Ltd., (376930.KR), an On-Device AI healthcare company, announced that the results of a clinical performance study of its malaria diagnostic solution showed a sensitivity of 94.4%, and a specificity of 98.1%, which is almost equivalent to WHO-certified first-degree microscopy experts. Read MoreEvent | 2024.04.25
-
Noul, a top On-Device AI healthcare company, joins CancerX, a cancer-fighting project led by the U.S. White House As part of the Cancer Moonshot initiative announced at the White House, noul is delighted to announce its groundbreaking participation as a leading On-Device AI healthcare company in the private-public partnership, CancerX. Congratulations on noul’s efforts to take a step closer to global cancer conquest! CancerX was… Read MoreNews | 2024.02.26
- Career Join our team, committed to
making a positive impact - View More
- Sustainability at Noul Sustainability is
at the core of our business philosophy. - Sustainability
